Cargando…
CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
Therapy resistance is a significant concern while treating malignant disease. Accumulating evidence suggests that a subset of cancer cells potentiates tumor survival, therapy resistance, and relapse. Several different pathways regulate these purported cancer stem cells (CSCs). Evidence shows that th...
Autores principales: | Molczyk, Caitlin, Singh, Rakesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953306/ https://www.ncbi.nlm.nih.gov/pubmed/36831112 http://dx.doi.org/10.3390/biomedicines11020576 |
Ejemplares similares
-
ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
por: Wei, Yaolu, et al.
Publicado: (2022) -
CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis
por: Zhang, Yang, et al.
Publicado: (2018) -
CXCR4-Directed Imaging in Solid Tumors
por: Werner, Rudolf A., et al.
Publicado: (2019) -
The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
por: Ruffini, Pier Adelchi
Publicado: (2019) -
Integrins regulate stemness in solid tumor: an emerging therapeutic target
por: Xiong, Jiangling, et al.
Publicado: (2021)